Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome

C. Michel Harper, Andrew G. Engel

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome'. Together they form a unique fingerprint.